23/05/2022
Super thrilled to be a part of the founding team of the Pan India Medical Cannabis & H**p Association (PIMCHA), driving the growth of a responsible, sustainable and inclusive medical cannabis and h**p ecosystem in India.
We strongly believe in cannabis’ far-reaching benefits to healthcare, agriculture and the environment and look forward to supporting ’s efforts to create a conducive environment which will accelerate the growth of the h**p industry in India while ensuring improved outcomes for patients and farmers alike
**pAssociation
23/05/2022
BrightMa Farms to Develop Carbon-Negative Cement Products With Recent Partnership
The company announced that it has partnered with SonoAsh to make low-carbon green cement products using industrial h**p.
09/12/2021
Hello world! Meet Cannarc.
We are under mass development and recognition process. Please bear with us, your patience and support will go a long way.
In the meantime, We are open to suggestions for a public service logo and all designs are welcome, the best 5 selections will get a goody bag from Cannarc!
For more information, drop a message or directly can reach out to Dhruv
Live happy, live free.
Sahil
06/09/2021
Commentary: Herbal Cannabis Vaporization Safer Alternative to Smoking - NORML
"Cannabis vaporizer use can reduce the emission of carbon monoxide, chronic respiratory symptoms, and exposure to several toxins,” researchers concluded.
06/09/2021
Study: Cannabis Consumers More Likely to Engage in Physical Activity - NORML
Investigators concluded, "Our findings do not support the mainstream perception of cannabis users as living sedentary lifestyles.”
06/09/2021
Daily Ma*****na Consumers Exhibit Insignificant Changes in Simulated Driving Performance After Smoking - NORML
Compared to occasional users and non-users, daily consumers displayed insignificant changes in SDLP following cannabis inhalation and drove at slightly slower speeds.
06/09/2021
Oral Cannabis Preparations Associated with Modest Improvements in Patients with Refractory Migraines - NORML
These results "suggest a role of the oral cannabinoid preparations in patients” with chronic migraines.